Oculis Holding AG
NASDAQ:OCS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Oculis Holding AG
NASDAQ:OCS
|
CH |
|
Collegium Pharmaceutical Inc
NASDAQ:COLL
|
US |
|
Taiga Building Products Ltd
TSX:TBL
|
CA |
|
Westport Fuel Systems Inc
TSX:WPRT
|
CA |
|
Noho Inc
OTC:DRNK
|
US |
|
Mobico Group PLC
LSE:MCG
|
UK |
|
Unionman Technology Co Ltd
SSE:688609
|
CN |
|
K
|
K Seng Seng Corporation Bhd
KLSE:KSSC
|
MY |
|
Cahayasakti Investindo Sukses Tbk PT
IDX:CSIS
|
ID |
|
XORTX Therapeutics Inc
NASDAQ:XRTX
|
CA |
|
S
|
Safeture AB
STO:SFTR
|
SE |
|
M
|
MMAG Holdings Bhd
KLSE:MMAG
|
MY |
|
P
|
Panda Financial Holding Corp Ltd
SSE:600599
|
CN |
|
FAN Communications Inc
TSE:2461
|
JP |
|
A
|
Atos SE
XBER:AXI
|
FR |
|
Rayitek Hi-Tech Film Co Ltd Shenzhen
SSE:688323
|
CN |
Bankruptcy Probability
Oculis Holding AG's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Oculis Holding AG Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CH |
O
|
Oculis Holding AG
NASDAQ:OCS
|
1.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
865.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
577.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
243.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.2B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
225.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
155.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Oculis Holding AG's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Oculis Holding AG has total debt of 1.8m CHF. This includes both short-term (0 CHF) and long-term (1.8m CHF) debt.
You can find a full breakdown on its Balance Sheet.